VOLUME 63 2002 NUMBER 1
CME Pretest 3
CME Posttest 86
Editorial
4 Gratitude. Alan J. Gelenberg
[PDF]
Brainstorms
7 The Psychopharmacology of Energy and Fatigue. Stephen M. Stahl
[PDF]
Original Articles
9 Ethnicity and Treatment Response in Schizophrenia: A Comparison of 3 Ethnic
Groups. Robin A. Emsley, Mimi C. Roberts, Solomon Rataemane, Janus Pretorius,
Piet P. Oosthuizen, Jadri Turner, Dana J. H. Niehaus, Natasha Keyter, and Dan
J. Stein
[Abstract]
[PDF]
15 Open-Label Topiramate as Primary or Adjunctive Therapy in Chronic Civilian
Posttraumatic Stress Disorder: A Preliminary Report. Jeffrey Berlant and
Daniel P. van Kammen
[Abstract]
[PDF]
21 Obsessive-Compulsive Hoarding: Symptom Severity and Response to Multimodal
Treatment. [CME] Sanjaya Saxena, Karron M. Maidment, Tanya Vapnik, Gina Golden,
Tanya Rishwain, Richard M. Rosen, Gerald Tarlow, and Alexander Bystritsky
[Abstract]
[PDF]
28 An Open-Label Trial of Sibutramine in Obese Patients With Binge-Eating Disorder.
Jose C. Appolinario, Amelio Godoy-Matos, Leonardo F. Fontenelle, Lucia Carraro,
Monica Cabral, Andrea Vieira, and Walmir Coutinho
[Abstract]
[PDF]
31 Reboxetine, a Selective Norepinephrine Reuptake Inhibitor, Is an Effective
and Well-Tolerated Treatment for Panic Disorder. Marcio Versiani, Giovanni
Cassano, Giulio Perugi, Alessandra Benedetti, Luigia Mastalli, Antonio Nardi,
and Mario Savino
[Abstract]
[PDF]
38 Comparative Efficacy of SSRIs and Amisulpride in Burning Mouth Syndrome:
A Single-Blind Study. Giuseppe Maina, Alberto Vitalucci, Sergio Gandolfo,
and Filippo Bogetto
[Abstract]
[PDF]
44 An Open-Label Study of Citalopram in the Treatment of Pathological Gambling.
Mark Zimmerman, Robert B. Breen, and Michael A. Posternak
[Abstract]
[PDF]
49 Attitudes Toward Antipsychotics Among Outpatient Clinic Attendees With Schizophrenia.
[CME] Alex Hofer, Georg Kemmler, Ursula Eder, Michaela Honeder, Martina Hummer,
and W. Wolfgang Fleischhacker
[Abstract]
[PDF]
54 Vitamin B6 as Add-On Treatment in Chronic Schizophrenic and Schizoaffective
Patients: A Double-Blind, Placebo-Controlled Study. Vladimir Lerner, Chanoch
Miodownik, Alexander Kaptsan, Hagit Cohen, Uri Loewenthal, and Moshe Kotler
[Abstract]
[PDF]
59 Posttraumatic Stress Disorder and Quality of Life: Results Across 64 Weeks
of Sertraline Treatment. Mark H. Rapaport, Jean Endicott, and Cathryn M.
Clary
[Abstract]
[PDF]
66 A Randomized, Double-Blind, Fixed-Dose Comparison of Paroxetine and Placebo
in the Treatment of Generalized Social Anxiety Disorder. Michael R. Liebowitz,
Murray B. Stein, Manuel Tancer, David Carpenter, Rosemary Oakes, and Cornelius
D. Pitts
[Abstract]
[PDF]
Letters To the Editor
75 Valproate-Induced Parkinsonism in a Demented Elderly Patient. Masaaki
Iijima
[PDF]
75 Hyperinsulinemia in Psychiatric Patients Treated With Olanzapine. Tony
A. Cohn, Gary Remington, and Homa Kameh
[PDF]
76 No Complications With Risperidone Treatment Before and Throughout Pregnancy
and During the Nursing Period. T. Ratnayake and Susan E. Libretto
[PDF]
77 The Clinical Features of Bipolar Depression. Franco Benazzi • Reply
by Philip B. Mitchell
[PDF]
78 Hemodialysis in the Treatment of Valproic Acid Overdose. Phillip Kroll
and Cheta Nand
[PDF]
Book Reviews 80
NOW@Psychiatrist.com 88
Information for authors
see January 2002, page 83 or our Web site at www.psychiatrist.com/author.htm